Infectious diseases expert Allison Bartlett, MD, answers common questions about the flu vaccine to help assuage any doubt that the flu shot is well worth the needle prick.
In 2020, an mRNA vaccine platform was approved for mass use for the first time to help combat the COVID-19 pandemic. Infectious disease expert Kathleen Mullane, DO, PharmD, has helped lead the Moderna vaccine clinical trial at the University of Chicago Medicine, and she’s here to share some information about how the mRNA vaccine platform works, and how we know it’s safe.
Millions of high-risk people have received the COVID-19 vaccine. However, a vaccination suitable for children younger than 16 years is still in the works.